Health ❯Healthcare ❯Clinical Research

Patient Studies

COVID-19 and Obesity Cardiovascular Events Outcomes Analysis Cancer Progression Cancer Research

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks

The pill form of the diabetes drug Rybelsus demonstrates significant cardiovascular benefits in a major clinical trial.

New Studies Confirm Safety of Semaglutide for Mental Health